Postoperative Pain Management Market Analysis

Nerve Blocks Market to Reach USD 9.4 Billion by 2033 at 6.4% CAGR

Postoperative analgesia, spanning orthopedic, thoracic and urologic procedures, constitutes the dominant indication, underpinned by ERAS guideline mandates and Joint Commission opioid-reduction metrics that create institutional procurement pull. Multiple 2025 trials address specific postoperative block protocols: TAP block for appendectomy (nct:NCT06943456), rectus sheath block adjuvant for hernioplasty (nct:NCT07062497), and multimodal TKA block comparison (nct:NCT07242170). CMS inpatient prospective payment bundling for joint replacement (MS-DRG 469/470) creates cost-reduction incentives that favor same-day discharge facilitated by effective peripheral nerve blockade.